Effect of systemic and extra-fine particle inhaled corticosteroids on corrected alveolar nitric oxide (CANO) in COPD

P. Williamson, P. Short, B. Lipworth (Dundee, United Kingdom)

Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Session: Drug delivery and pharmacokinetics I
Session type: Thematic Poster Session
Number: 829
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Williamson, P. Short, B. Lipworth (Dundee, United Kingdom). Effect of systemic and extra-fine particle inhaled corticosteroids on corrected alveolar nitric oxide (CANO) in COPD. Eur Respir J 2011; 38: Suppl. 55, 829

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002



Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma
Source: Eur Respir J 2001; 18: 635-639
Year: 2001



Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 270s
Year: 2004

Onset of action of inhaled corticosteroids on bronchial and alveolar nitric oxide output
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020


Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008

Optimising inhaled corticosteroid (ICS) dose using exhaled nitric oxide (eNO) measurements
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003

Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

Comparison of long-acting inhaled beta2–agonists plus inhaled steroids versus increasing dose of inhaled steroids on exhaled nitric oxide among asthmatic children poorly controlled
Source: Eur Respir J 2005; 26: Suppl. 49, 617s
Year: 2005

Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 259s
Year: 2004

Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001

Effect of salbutamol and budesonide on nitric oxide diffusion and temperature gradients in the airways
Source: Eur Respir J 2004; 24: Suppl. 48, 339s
Year: 2004

Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 429s
Year: 2004

Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002



Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels
Source: International Congress 2017 – Monitoring asthma control
Year: 2017

Tapering oral corticosteroids in severe asthma is associated with a decrease in fractional exhaled nitric oxide
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011

Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008

Comparison of hemodynamic effects of inhaled nitric oxide (iNO) and inhaled epoprostenol (iEPO) in patients with pulmonary hypertension (PH)
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011

Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study
Source: Eur Respir J 2014; 44: 1705-1707
Year: 2014